Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Indian Journal of Ophthalmology|June 1, 2022
Safety, efficacy, and patient selection of ripasudil in patients with uncontrolled glaucoma with maximum conventional medical therapyJignesh Jethva, Purvi Bhagat, Kamini Prajapati, et al.International Journal of Applied & Basic Medical Research|December 16, 2021
Changing Assessment Scenarios: Lessons for Changing PracticeShaista Saiyad, Purvi Bhagat, Amrit Virk, et al.Clinical Ophthalmology (Auckland, N.Z.)|June 9, 2016
Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucomaTejaswini Walimbe, Vidya Chelerkar, Purvi Bhagat, et al.International Ophthalmology|August 26, 2025
Prevalence and clinical characteristics of Charles Bonnet syndrome in patients with glaucomaAhan Banker, Divya Patel, Mahir Patel, et al.The National Medical Journal of India|June 22, 2026
A structured, mentored experiential clinical research programme for undergraduate studentsMinakshi Parikh, Purvi Bhagat, Amita Himanshu Sutaria, et al.Clinical Ophthalmology (Auckland, N.Z.)|July 26, 2014
Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertensionPurvi Bhagat, Kalyani Sodimalla, Chandrima Paul, et al.Cureus|December 16, 2024
Efficacy and Safety of a Fixed-Dose Combination of Brinzolamide 1%/Timolol 0.5% vs. Dorzolamide 2%/Timolol 0.5% in Indian Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: A Randomized Phase 3 StudyPurvi Bhagat, Mukesh Singhania, Sujata Navare, et al.Indian Journal of Ophthalmology|June 22, 2021
Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1Mrittika Sen, Santosh G Honavar, Rolika Bansal, et al.Pageof 1